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Abstract
Damage initiates a pleiotropic cellular response aimed at cellular survival when appropriate. To identify genes required for
damage survival, we used a cell-based RNAi screen against the Drosophila genome and the alkylating agent methyl
methanesulphonate (MMS). Similar studies performed in other model organisms report that damage response may involve
pleiotropic cellular processes other than the central DNA repair components, yet an intuitive systems level view of the
cellular components required for damage survival, their interrelationship, and contextual importance has been lacking.
Further, by comparing data from different model organisms, identification of conserved and presumably core survival
components should be forthcoming. We identified 307 genes, representing 13 signaling, metabolic, or enzymatic pathways,
affecting cellular survival of MMS–induced damage. As expected, the majority of these pathways are involved in DNA repair;
however, several pathways with more diverse biological functions were also identified, including the TOR pathway,
transcription, translation, proteasome, glutathione synthesis, ATP synthesis, and Notch signaling, and these were equally
important in damage survival. Comparison with genomic screen data from Saccharomyces cerevisiae revealed no overlap
enrichment of individual genes between the species, but a conservation of the pathways. To demonstrate the functional
conservation of pathways, five were tested in Drosophila and mouse cells, with each pathway responding to alkylation
damage in both species. Using the protein interactome, a significant level of connectivity was observed between Drosophila
MMS survival proteins, suggesting a higher order relationship. This connectivity was dramatically improved by incorporating
the components of the 13 identified pathways within the network. Grouping proteins into ‘‘pathway nodes’’ qualitatively
improved the interactome organization, revealing a highly organized ‘‘MMS survival network.’’ We conclude that
identification of pathways can facilitate comparative biology analysis when direct gene/orthologue comparisons fail. A
biologically intuitive, highly interconnected MMS survival network was revealed after we incorporated pathway data in our
interactome analysis.
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Introduction
Cellular damage is a normal component of life, with constant
damage exposure from both endogenous and exogenous sources.
Damage to DNA is considered to be the most biologically relevant
lesion with the potential of mutagenic results, though most
exogenous agents have the potential to damage many components
of the cell. Responding appropriately to such insults, either
mitigating cellular toxicity or initiating an appropriate cell death
response, is critical, particularly in multi-cellular organisms.
Inappropriate responses may facilitate deleterious effects, such as
a destabilized genome and diseases such as cancer [1]. As such,
DNA damage response (DDR) components are critical suppressors
of deleterious effects of genotoxic agents by controlling cell cycle
progression, DNA repair, and apoptosis [2]. For this reason, there
have been many investigations using a variety of model organisms
to identify components of DDR and subsequently to determine
how they function and the consequences of their dysfunction.
Recent reports suggest that DDR may involve pleiotropic cellular
processes other than the central DDR components [3,4], yet an
intuitive systems level view of the cellular components required for
damage survival, their interrelationship, and their contextual
importance has been lacking. The most comprehensive attempt at
understanding the interrelationship of damage response and
survival components in yeast at a systems level has been mapping
identified genes to a network by integrating the general biological
processes as distinct modules [5]. It has been suggested that the
inclusion of well-defined biological pathways in protein networks
might provide a better understanding of biological interactions
therein [6,7].
In order to identify genes involved in damage response in an
unbiased manner and to put them in a functional context, we used
an RNAi library [8] to knock-down every predicted protein in the
Drosophila melanogaster genome and assessed whether knock-down of
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methyl methanesulfonate (MMS) exposure. MMS is a prototypical
alkylating agent that attacks nucleophilic groups, such as those
found in nucleic acid [9]. The resultant base methylation
destabilizes the glycosidic bond, facilitating the production of the
most biologically relevant cellular lesion of MMS, an abasic site in
DNA. Other common sources of alkylation damage include
endogenous S-adenoysyl methionine [10], the tobacco carcinogen
N-nitorsoamine [11] and chemotherapeutics such as temozolo-
mide [12], carmustine (BCNU) [9], and cyclophosphamide [13].
Considering the physiological relevance of alkylation damage,
several recent studies using yeast as model organism investigated
the global effects of alkylation damage induced by MMS. Viability
[14], gene transcription [15] and protein expression [16] were
measured in these studies, all of which provided insights into the
diverse nature of biological responses to alkylation damage.
However when transcriptional responses to various environmen-
tal stresses were compared between mammalian and yeast cells
[17], Murray et al. reported clear distinctions and suggested that
this might be the result of different selective pressures between
multi-cellular organisms and single-cell organisms. In the
attempt to understand diverse responses required for damage
survival in a system that is evolutionarily closer to mammals
than yeast, we performed a genome-wide, RNAi-based screen
using cells derived from Drosophila melanogaster. Our experiments
were based on ‘‘loss of function’’ and an assessment for cellular
viability following exposure to MMS. Here we present results
from this MMS survival screen, the pathways that were
identified, and a comparative analysis of pathways to understand
conservation of these pathways in yeast and mouse cells.
Additionally, we present a novel approach of assembling a
protein interaction network based on defined biological path-
ways, which facilitates network consolidation. By including
biological pathways in our genomic data and protein network
analysis, we were able to determine the commonality across
species, which was obscured by direct orthologue comparison,
and provide a simplified representation of the global survival
responses that we identified.
Results
Genome-wide RNAi screen and validation
An RNAi screen was designed to identify those genes that
modulate cellular survival following exposure to a level of MMS-
induced damage that resulted in only a limited amount of cell
death. A linear decrease in cell viability was observed from 0.002%
(w/v) of MMS to 0.008% (w/v) of MMS (Figure S1). A dose of
0.004% (w/v; 40 mg/mL) MMS was chosen, which resulted in a
statistically significant decrease to approximately 65% viability,
while allowing an additional, measurable decrease in cell survival.
RNAi screens were performed using the Drosophila RNAi
Screening Center (DRSC) version 1 library (about 23,000 D.
melanogaster open reading frames) [8]. Kc167 Drosophila cells were
exposed to three days of dsRNA to allow protein knock-down,
followed by three days of growth in either the absence or presence
of MMS exposure (Figure 1A).
To identify those genes required for cell viability following
MMS treatment, viability results from the MMS treated RNAi
screen were compared with that of the untreated (control) screen
as previously described [18]. 1,398 different open reading frames
were identified that affected MMS survival in a continuous
distribution of cell survival values (see [18] and http://gccri.
uthscsa.edu/ABPublished_Data.asp for original data), of which
996 had a unique assigned FlyBase gene number (FBgn; denotes
known genes) (see Figure 1B and Table 1). Of these 996 genes, the
top 537 were selected for validation analysis by a previously
described, stringent validation method [18]. Whereas in [18] we
validated normalization methods, here we independently validated
individual genes using dsRNA targeting a different region of each
gene. 202 protein knock-downs validated with a significant MMS
viability effect, while 55 more had a notable trend effect without
meeting our stringent statistical criteria (Table S1 and Table S2).
An examination of gene ontology (GO) on the 202 validated MMS
survival genes revealed a significant enrichment for genes involved
in DNA metabolism, gene transcription, and cellular metabolism
(Table 2). The overall variety of GO categories observed was quite
broad, consistent with the findings reported for an analogous yeast
screen [3] (data not shown). Surprisingly though, no significant
enrichment between the gene orthologues for the two organisms
was observed (G-test p-values of 0.29 and 0.057 or Fisher Exact
test p-values of 0.37 and 0.08, yeast and fly, respectively). To
further test this, we examined the MMS sensitivity following
knock-down of 183 fly genes that were orthologues of to 118 yeast
MMS survival genes [3], but only found conservation of MMS
survival phenotype with 20 (Table S3). This apparent lack of gene
enrichment between species has also been reported when
comparing transcriptional profiles between mammalian and yeast
cells in response to a variety of stresses [17]. Overall, these results
suggest that there may be conservation of the biological processes
that respond to MMS rather than the individual genes.
Identification of pathways responsive to MMS
Assuming that biological function is a more informative
measure of damage response than a requirement of individual
genes, we therefore endeavoured to identify those MMS survival
proteins within known signaling, metabolic, and enzymatic
pathways. Using both a priori knowledge and KegArray, we
identified 13 pathways that together included 41 MMS survival
proteins (Figures 1, 2, 3 and Figures S2, S3, S4, S5), among them,
five DNA repair pathways (Base Excision Repair; Nucleotide
Excision Repair; Mismatch Repair; Homologous Recombination
Repair; and RECQ). Many of these pathways have a statistically
significant number of MMS survival proteins (Table S5), and this
Author Summary
Cellular damage is known to elicit a pleiotropic response,
but the relative importance of the constituent compo-
nents in cell survival is poorly understood. To provide an
unbiased identification of the proteins utilized in damage
survival, we performed an RNAi survival screen in fly cells
with methyl methanesulfonate (MMS). The genes identi-
fied are involved in 13 biologically diverse pathways.
Comparison with analogous yeast data demonstrated a
lack of conservation of the individual MMS survival genes
but a conservation of pathways. We went on to
demonstrate the MMS responsiveness for five representa-
tive pathways in both fly and mouse cells. We conclude
that identification of pathways can facilitate comparative
biology analysis when direct gene/orthologue compari-
sons fail. Incorporation of pathway data in interactome
analysis also improved connectivity and, more importantly,
revealed a biologically intuitive, highly inter-connected
‘‘MMS survival network.’’ This pathway conservation and
inter-connectivity implies extensive interaction between
pathways; for diseases such as cancer, such crosstalk may
dictate disparate cellular responses not necessarily expect-
ed and confound treatments that are not tailored to the
individual molecular context.
Damage Survival Pathways
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Considering the likely role of these pathways in MMS survival, we
used an RNAi assay method, which is both more sensitive and
stringent than the original screen [18], to determine whether other
members of the 13 identified pathway also affected MMS survival
(Table S1). By individually interrogating the 346 pathway
members of the 13 pathways that were not identified in the
original screen, an additional 105 MMS survival genes were
discovered. This observation significantly enriched the number of
MMS survival genes in each of the 13 pathways (Figures 1, 2, 3
and Figures S2, S3, S4, S5) and provides additional support to the
hypothesis that each of the identified pathways are involved in
MMS survival. Though this result highlights the possibility of false
negative screen data, compared to our previous false negative rate
of 23.6% from randomly selected data, we observe a significant
enrichment for false negatives within pertinent pathways ((x
2
p=3.9E-5). In total we identified 146 MMS survival genes in 13
‘‘MMS survival pathways,’’ encompassing 25% to 86% of all non-
essential genes within each pathway (Table S4).
Using the genes we mapped to the MMS survival pathways, we
then compared pathways identified from our Drosophila MMS
screen with the analogous screen performed in yeast [14] using
Figure 1. The experimental design of the Drosophila RNAi MMS survival screen and summary of the workflow and results. (A) A
schematic representation of the experimental design used to screen for genes involved in survival of an MMS exposure using RNAi in Drosophila. (B) A
schematic representation of the workflow from the initial RNAi screen, the normalization and validation of results, and the follow-up work conducted,
with a summary of the number of dsRNA amplicons and genes (FBgn; FlyBase gene number) involved at each step in the process. Also provided are
the final numbers of MMS survival proteins and MMS survival pathways (BER: base excision repair; NER: nucleotide excision repair; MMR: mismatch
repair; HRR: homologous recombination repair; RECQ: RecQ helicases; DDR: DNA damage response; Proteasome; GSH: glutathione synthesis; TOR:
TOR pathway; Transcription: basal transcription; Ribosome; ATPase; Notch: Notch signaling pathway).
doi:10.1371/journal.pgen.1000527.g001
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we did not observe a significant overlap between the two screens
when comparing MMS survival gene orthologues, however, with
this pathway comparison, we mapped orthologues of yeast MMS
survival genes to 10 of the 13 Drosophila MMS survival pathways
(Figures 2 and 3; Figures S2, S3, S4, S5; Table S6). The three
Drosophila MMS survival pathways without yeast MMS survival
genes either are not conserved in yeast or have almost all of the
pathway components are essential for viability in yeast, thus
making them refractory to MMS viability analysis (Table S5). The
gene enrichment with each pathway between species is highly
supportive of a conservation of processes involved in MMS
survival. A notable absentee in the Drosophila screen, which was
observed in yeast, is 3-methyladenine-DNA-glycosylase (MAG1/
AlkA), the principal protection against MMS-induced DNA
damage in yeast, but no direct orthologues exist in animals. One
of the two glycosylase found in Drosophila that act at the same step
in BER, namely Thd1, was found to be required for survival after
MMS treatment. Furthermore, several of the pathways observed
in both species, such as proteasome [19], the TOR pathway [20],
and DNA repair pathways [21], have been shown to be
functionally responsive to MMS in yeast. Altogether, these results
suggest a conservation of pathway function, if not individual genes,
in response to MMS between species.
To demonstrate that the identified Drosophila pathways are
functioning in the expected manner in response to MMS, five were
selected for further examination – base excision repair (BER),
DDR, glutathione metabolism, proteolysis by proteasomal degra-
dation (proteasome), and the TOR pathway. Two of these
pathways, BER and DDR, are expected to play a role in MMS
survival [9], while the others were selected for their apparent
breadth of function and their non-canonical role in damage
survival. For each pathway, an appropriate functional assay was
chosen, and when possible, an appropriate upstream MMS
survival protein within that pathway was knocked-down (Figure
S6A) to demonstrate modulation of the MMS induced response.
Functional conservation of MMS survival pathways in
Drosophila and mouse
First, we tested the two expected MMS survival pathways BER
and DDR. MMS-induced DNA damage results in the production
of apurinic/apyrimidic (AP) sites, a DNA damage typically
repaired by BER [9]. We therefore quantified the amount of AP
sites per microgram of genomic DNA following MMS treatment
and observed a statistically significant increase compared to
control (Figure 4A; p#7.6E-8). Knock-down of the BER
component XRCC1 resulted in an increased amount of AP sites
in and of itself (p#3E-3), but following MMS treatment, the
amount of AP sites in the absence of XRCC1 was increased
further (Figure 4A; compared with untreated XRCC1 knock-
down, p#3.3E-8; compared to MMS treated luciferase (Luc)
control, p#3.7E-3); MMS therefore produces the expected form
of DNA damage to which BER appropriately responds. p53, a
central component of the DDR pathway, is regulated at
expression, protein stabilization, and posttranslational modifica-
tion levels. As expected, p53 gene expression increased in response
to MMS exposure (Figure 4B; p#1.6E-3).
We then examined three MMS survival pathways that are not
part of the canonical DDR and DNA repair process: glutathione
metabolism, proteasome, and the TOR pathway. An increased
activity of the glutathione synthesis pathway following MMS
exposure was demonstrated by measuring total glutathione
content per milligram of protein lysate (Figure 4C; p#3.4E-3),
as well as by examining the expression of the rate-limiting enzyme
for glutathione synthesis, GCLc [22] (p#8.8E-4). Therefore, as
expected, knock-down of this same protein, GCLc, significantly
reduced the total amount of glutathione present compared with
control (p#3.4E-3), but its knock-down also prevented the cells
from increasing the level of glutathione in response to MMS
exposure (Figure 4C). Since glutathione synthesis is considered to
be an oxidative stress response, we demonstrated that MMS
resulted in a dose-dependent increase in the level of 8-oxoguanine,
a DNA lesion normally associated with oxidative damage (Figure
S7 and Text S1). Thus it appears that MMS results in not only
alkylation damage but also damage from oxidative stress.
For the analysis of the proteasome degradation pathway, we
measured proteasome activity and found that it increased
following MMS treatment (Figure 4D; p#4.2E-2). Protein
knock-down of the proteasome components Rpn2 or Pros26.4
significantly reduced proteasome activity compared to cells
without knock-down that were either unexposed (Rpn2:
p#1.7E-2; Pros26.4: p#3.7E-3) or exposed to MMS (Rpn2:
p#1.4E-4; Pros26.4: p#7.0E-5). Following Rpn2 knock-down,
cells were unable to mount a detectable increase in proteasome
activity following MMS exposure, although we were unable to
demonstrate this for Pros26.4 knock-down (p#1.7E-3). Overall, it
appears that MMS exposure results in increased proteasome
activity.
Finally, to investigate TOR pathway activity, S6K phosphor-
ylation status was monitored. TOR is a kinase that phosphorylates
S6K to promote growth through ribosome biogenesis and is
negatively regulated by the tumor suppressor protein Tsc1 [23].
MMS exposure resulted in a dose-dependent decrease in S6K
phosphorylation, suggesting an inhibition of TOR activity
(Figure 4E). This MMS-induced decrease in S6K phosphorylation
was dependent on Tsc1 (Figure 4E). MMS exposure therefore
elicited a down-regulation of the growth promoting TOR
pathway, suggesting that this pathway is also a coordinated
component of DDR similar to observations in yeast [20]. This
supports a previously published observation by Matsuoka et al. [4],
who showed that some components of the mammalian TOR
pathway are phosphorylated following ionizing radiation expo-
sure. In conclusion, the results of these functional assays validate
the identification of the ‘‘MMS survival pathways’’ by RNAi
screening and that the functionality of these pathways, or lack
thereof, affects MMS survival.
Having thus identified 13 Drosophila MMS survival pathways, we
went on to investigate their functional conservation in mammals.
Using primary mouse embryonic fibroblasts (MEFs), we examined
the same five pathways that were modulated following MMS
Table 1. Summary of MMS survival genes identified by
genome-wide RNAi screen.
Normalized RNAi screen results
Death Resistance Total
BS_QN 1183 40 1223
cellHTS2 594 40 634
total 1326 72 1398
FBgn 935 61 996
Numbers of death and resistance hits found by background subtraction
followed by quantile normalization (BSQN) and cellHTS2 are given. The total
number of unique hits and the total number of hits whose amplicons map to
genes with FlyBase gene number (FBgn) are also given.
doi:10.1371/journal.pgen.1000527.t001
Damage Survival Pathways
PLoS Genetics | www.plosgenetics.org 4 June 2009 | Volume 5 | Issue 6 | e1000527Table 2. Categories of Gene Ontology enrichment within the validated MMS survival genes.
Gene Ontology enrichment
Biological Process
Adjusted P-value GO Attribute
,0.001 0006139: nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
,0.001 0006351: transcription, DNA-dependent
,0.001 0032774: RNA biosynthetic process
,0.001 0016070: RNA metabolic process
,0.001 0045449: regulation of transcription
,0.001 0065004: protein-DNA complex assembly
,0.001 0016043: cellular component organization and biogenesis
,0.001 0051252: regulation of RNA metabolic process
,0.001 0006367: transcription initiation from RNA polymerase II promoter
,0.001 0006355: regulation of transcription, DNA-dependent
,0.001 0065003: macromolecular complex assembly
,0.001 0008283: cell proliferation
0.001 0035080: heat shock-mediated polytene chromosome puffing
0.014 0006911: phagocytosis, engulfment
0.018 0045165: cell fate commitment
0.034 0030154: cell differentiation
0.049 0006259: DNA metabolic process
Molecular Function
Adjusted P-value GO Attribute
,0.001 0030528: transcription regulator activity
,0.001 0003676: nucleic acid binding
,0.001 0016251: general RNA polymerase II transcription factor activity
,0.001 0003702: RNA polymerase II transcription factor activity
0.003 0005515: protein binding
0.003 0043565: sequence-specific DNA binding
Cellular Component
Adjusted P-value GO Attribute
,0.001 0005634: nucleus
,0.001 0005654: nucleoplasm
,0.001 0043227: membrane-bounded organelle
,0.001 0031981: nuclear lumen
,0.001 0016591: DNA-directed RNA polymerase II, holoenzyme
,0.001 0031974: membrane-enclosed lumen
,0.001 0043234: protein complex
,0.001 0032991: macromolecular complex
,0.001 0005667: transcription factor complex
0.003 0000119: mediator complex
0.012 0008540: proteasome regulatory particle, base subcomplex
0.015 0005665: DNA-directed RNA polymerase II, core complex
0.032 0005675: holo TFIIH complex
0.038 0000123: histone acetyltransferase complex
An examination of the 202 validated screen MMS survival genes for category enrichment within Gene Ontologies; Biological Process, with 46 genes having no functional
annotation; Molecular Function, with 40 genes having no functional annotation; Cellular Component, with 68 genes having no cellular component annotation, using
FuncAssociate.
doi:10.1371/journal.pgen.1000527.t002
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in MEFs to Drosophila (compare Figures 4 and 5). MMS increased
the amount of AP sites in MEFs (Figure 5A); in the absence of
XRCC1, however, we observed a significant increase in AP sites
following MMS exposure (Figure 5A; p#3.7E-4). For DDR in
MEFs, we assessed the phosphorylation status of Chk1 (a kinase
that, once phosphorylated, phosphorylates p53) [24], total p53
protein, and the phosphorylation status of p53 (Figure 5B), not to
examine p53 expression levels, but to obtain a result equivalent to
that of Drosophila result: that DDR is activated by MMS exposure.
Also, similar to the observation in Drosophila cells, MEFs had
increased proteasome activity following MMS treatment
(Figure 5D; p#2.0E-4); knock-down of either proteasome
component, PSMC1 or PSMD1 (orthologues to Rpn2 and
Pros26.4, respectively), resulted in decreased proteasome activity
following MMS exposure (PSMC1: p#8.1E-5; PSMD1: p#4.1E-
4). These results are comparable with Drosophila: it is clear that
proteasome activity is responsive to MMS in MEFs. It should also
be noted that, though we were able to demonstrate the same dose-
dependent decrease in S6K phosphorylation following MMS
exposure in MEFs as seen in Drosophila cells (Figure 5E) and that
knock-down of TSC1 disrupted this MMS-induced effect, the
disruption was not as evident as observed with Drosophila, probably
due to inefficient knock-down of the TSC1 protein in MEFs (data
not shown). Having observed the functionality of these pathways in
response to MMS and the ability of the five siRNA to modulate
the MMS response of their respective pathway, we also examined
the effect of each knock-down on MMS survival in MEFs. Three
of the protein knock-downs, GCLC, PSMC1 and PSMD1,
affected MMS survival in MEFs (data not shown). Overall, it
would appear that Drosophila could be used to accurately predict
MMS survival pathways in mouse.
Utilization of the MMS survival pathways in response to
Temozolomide
Given that MMS causes alkylation damage, it would be
reasonable to suppose the identified biological pathways are
generally involved in the response to other alkylating agents.
Temozolomide is an alkylating agent used clinically in the
treatment of cancer [12,25]. It has already been demonstrated
that BER and TOR are necessary for Temozolomide survival
[12,25]. Temozolomide causes DNA damage by increasing the
number of AP sites, and similar to our MMS results, inhibition of
BER increases sensitivity to temozolomide [12]. It has also been
reported that rapamycin inhibition of the TOR pathway increased
cellular sensitivity to temozolomide [25]. To further demonstrate
the utilization of MMS survival pathways in response to
temozolomide, we examined the DDR pathway, glutathione
levels, and proteasome activity in MEFs and observed the same
responses as observed following MMS exposure (Figure S8).
Further, using HEK293 cells, we observed that both MMS and
temozolomide exposure repressed Notch reporter activity (Figure
S9 and Text S1). Absence of functional Notch protein has been
shown to repress the activity of a downstream transcriptional
activator (RBP-Jk) [26], therefore this result demonstrates a
functional Notch pathway response in alkylation damage expo-
sure. Taken together, these data suggest a functional conservation
of the MMS survival pathways responses with other similarly
acting agents.
Network integration of MMS survival pathways
Of the 307 identified MMS survival genes (202 validated screen
hits plus 105 from pathway analyses), we were able to assign 146 to
13 pathways (Figures 1, 2, 3 and Figures S2, S3, S4, S5). Because
161 MMS survival protein remain unassigned, we re-examined the
inter-relationship between the identified MMS survival proteins
using the currently available Drosophila protein:protein interactome
(PPI) map [27–29]. To measure the connectivity among the MMS
survival genes, we took the largest connected components of the
PPI network and discarded the other, smaller components. The
largest connected component contained 7364 of the 7504 proteins
in the original PPI network. Taking the 202 original validated
MMS screen hits as an unbiased starting point, we determined the
number of proteins that were directly connected to one another,
compared to a random set of the same number of proteins from
the PPI, and observed a significant enrichment (Figure 6A and
Table S7; p#2.1E-10). Similar results were obtained for other
assessments of network connectivity (Table S7). Because the MMS
screen hits had more connections on average than a set of random
genes, which might have biased the above analysis, we also
compared the connectivity of the MMS screen hits in the real PPI
network with the connectivity of the same set of proteins in a
randomly rewired PPI network. Degrees were preserved in the
random rewiring process. As shown in Table S7, the MMS screen
hits have statistically significantly more direct interactions than
would be expected in a randomly rewired network (p=0.01). On
the other hand, the randomized network had smaller average
distance and higher global efficiency than the real network, which
could be attributed to the well-known property of real-world
networks: they usually have slightly longer average distances (and
correspondingly, lower global coefficients) than their degree-
preserving randomly rewired counterparts [30].
Because we were unable to assess the effect of essential proteins
(proteins whose knock-down resulted in cell death regardless of
treatment) on MMS survival, we repeated the connectivity analysis
while including those essential proteins that were connected to two
or more MMS survival proteins, since these are the ones most
likely to have a functional role in MMS survival. This increased
the size and significantly improved the connectivity within the
resultant network (Figure 6B and Table S7; p#1.3E-26). After
pathway analysis, we identified an additional 105 MMS pathway
hits, which were validated. In order to expand the network to
include the proteins in these relevant pathways, these hits were
then incorporated and a larger, and equally well-connected
network was observed (Figure 6C and Table S7; p#4.6E-26).
Considering the apparent importance of pathways over the
individual genes, we then included all components of the 13
identified MMS survival pathways and observed that the
Figure 2. Base excision repair, DNA damage response, and proteasome pathways utilized for MMS survival. CG numbers are given for
each Drosophila pathway component, as well as the protein names or complex names for their human orthologues. Pathway entry points are noted
with Roman numerals at the top, and end points are at the bottom. A key for the following symbols is provided. Symbols encircled with thick lines
represent proteins that act together or in a complex, while symbols encircled with thin lines represent paralogues or proteins that may substitute for
one another. Proteins found to affect MMS survival are noted as down (death) or up triangles (resistance). Statistically significant proteins are
indicated with black triangles, while trend hits are indicated with grey triangles. Essential genes are noted with a thick bar and any with downwards
or upwards pointing boxes were also validated as conferring death or resistance, respectively, to MMS upon knock-down. Shaded squares are
proteins not found to be hits after validation, and open squares were not tested in our validation. Yeast orthologues previously found to be required
for MMS survival [3] are noted with a dot under the symbol. (A) Base Excision Repair. (B) DNA Damage Response. (C) Proteasome.
doi:10.1371/journal.pgen.1000527.g002
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improved yet again (Figure 6D and Table S7; p#4.6E-52). Similar
to the analysis of the 202 validated MMS screen hits, we also
compared the connectivity of the subnetworks containing the
essential genes or pathway hits with that of a randomly rewired
network consisting of the same nodes. Although at a lower
statistical significance, the same general trend was observed (Table
S7). This more inclusive network allows a view of all interactions
Figure 3. Glutathione and TOR pathways utilized for MMS survival. CG numbers are given for each Drosophila pathway component, as well
as the protein names or complex names for their human orthologues. Pathway entry points are noted with Roman numerals at the top, and end
points are at the bottom. A key for the following symbols is provided. Symbols encircled with thick lines represent proteins that act together or in a
complex, while symbols encircled with thin lines represent paralogues or proteins that may substitute for one another. Proteins found to affect MMS
survival are noted as down (death) or up triangles (resistance). Statistically significant proteins are indicated with black triangles, while trend hits are
indicated with grey triangles. Essential genes are noted with a thick bar and any with downwards or upwards pointing boxes were also validated as
conferring death or resistance, respectively, to MMS upon knock-down. Shaded squares are proteins not found to be hits after validation, and open
squares were not tested in our validation. Yeast orthologues previously found to be required for MMS survival [3] are noted with a dot under the
symbol. (A) Glutathione (an expanded list of GST family members is given in Table S4) and (B) TOR.
doi:10.1371/journal.pgen.1000527.g003
Damage Survival Pathways
PLoS Genetics | www.plosgenetics.org 8 June 2009 | Volume 5 | Issue 6 | e1000527Figure 5. Functional conservation in mouse embryonic fibroblasts of five pathways found to be utilized for MMS survival in
Drosophila cells. (A) MMS exposure results in an increase in AP sites, siRNA based XRCC1 knock-down results in an increased quantity of AP sites
following MMS exposure. (B) MMS exposure results in phosphorylation of CHK1 and p53 and in an accumulation of total p53 levels. (C) MMS exposure
results in an increased amount of total glutathione and this increase is partially dependent upon GCLc. The intracellular glutathione concentrationi s
expressed as mmoles/L normalized per mg protein. This GCLc dependency correlates with the increased level of GCLc expression observed following
MMS exposure. (D) Proteasome activity is increased following MMS exposure in a manner that is dependent upon proteasome components Pmsc1
and Psmd1. Proteasome activity is expressed as units of activity/cell, normalizing the activity to the number of cells using a parallel viability
assessment. (E) MMS exposure results in a dose-dependent decrease in the phosphorylation of p70S6K. Statistically significant differences between
unexposed and MMS exposed cells are denoted (*; **; ***; with p-values of ,0.05; ,0.01; and ,0.001 respectively) as are differences between NT
control and each siRNA knock-down (#; ##; ###; with p-values of ,0.05; ,0.01; and ,0.001 respectively).
doi:10.1371/journal.pgen.1000527.g005
Figure 4. An examinationofthe functionalityoffiveofpathways utilized inMMS survival byDrosophila cells. (A) MMS exposure results in
an increase in AP sites. dsRNA knock-down of the BER component XRCC1 increases the quantity of AP sites observed following MMS exposure. (B) MMS
exposure results in increased p53 expression by quantitative real-time PCR analysis; expression level is provided as fold change compared to an
endogenous control (CG6905). (C) MMS results in an increased amount of total glutathione, and this increase is dependent upon the rate limiting
glutathione metabolizing enzyme glutamate cysteine ligase (GCLc). The intracellular glutathione concentration is expressed as mmoles/L normalized per
mg protein. This GCLc dependency correlates with the increased level of GCLc expression observed following MMS exposure. (D) Proteasome activity is
increased following MMS exposure in a manner that is dependent upon proteasome components Rpn2 and Pros26.4. Proteasome activity is expressed as
units of activity/cell, normalizing the activity to the number of cells using a parallel viability assessment. (E) MMS exposure results in a dose-dependent
decrease in the phosphorylation of the dTor component p70S6K. This decrease is dependent upon the negative regulator of dTor, Tsc1. Statistically
significant differences between unexposed and MMS exposed cells are denoted (*; **; ***; with p-values of ,0.05; ,0.01; and ,0.001 respectively) as are
differences between Luc control and each dsRNA knock-down (#; ##; ###; with p-values of ,0.05; ,0.01; and ,0.001 respectively).
doi:10.1371/journal.pgen.1000527.g004
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components themselves are not critical to survival after MMS. To
qualitatively visualize this result, each protein known to be in a
pathway was grouped together and assigned to a ‘‘pathway node’’
(a single node within the interactome that retains the interactions
of its constitutive proteins to proteins that are external to that
pathway). This resulted in a highly connected interactome, or
‘‘MMS survival network’’ (Figure 6E), that now encompassed 179
of the 233 MMS survival proteins that are present in the PPI
network (77%). Of the remaining 54 orphan proteins, 47 are only
one protein removed from the MMS survival network, six are two
proteins away, and only one is not connected at all. At each step in
this analysis, we observed an improved network, either enlarged or
better connected, not only when comparing the entire set of
proteins in that network to a random set of proteins in the PPI, but
also when randomizing the additional proteins added at each step
(data not shown). Overall, our observations with the MMS survival
network suggest that despite the general interconnectivity within
protein interactomes, a pathway analysis is highly relevant because
it may improve interactome connectivity and it simplifies a systems
biology overview.
Discussion
Studies performed using yeast as a model organism to predict
network response to MMS reported an astounding involvement
of diverse biological pathways [31]. Considering that the genes
that respond to environmental stress differ between mammalian
and yeast cells [17], we presumed that damage response might
be different or more complex in higher eukaryotes, especially
considering the presence of paralogues and thus increased
genetic redundancy. We therefore performed a genome-wide,
RNAi based screen with Drosophila cells to investigate which
genes are essential for survival following damage exposure with
MMS. We were able to identify and validate 307 MMS survival
genes, the majority of which had not previously been associated
with alkylation damage survival. Of these genes, 146 were
components of 13 different MMS survival pathways. With the
five pathways examined in detail, we observed that four were
functionally conserved in yeast and all five conserved in mouse
with regard to their utilization following MMS treatment
(Figure 5). In yeast, experimental validation of response to
MMS by proteasome [19], the TOR pathway [20], and DNA
repair pathways [21] was previously reported. Similarly,
glutathione response to MMS was observed in mammalian cells
[32], and our observation of an increase in GCLc expression
provides an underlying mechanism for this phenomenon. Our
demonstration of a dose-dependent increase in 8-oxoguanine after
MMS exposure indicates that MMS also results in oxidative stress
damage, as previous studies suggested [33]. Additionally, several
recent studies have demonstrated a role for the proteasome in
regulating several DNA repair pathways (reviewed in [34]),
supporting our observation of increased proteasome activity in
response to MMS.Thus, our screen and pathway identification have
revealed a conserved set of MMS survival pathways.
Our Drosophila based study has provided novel insights to the
global cellular response to alkylation damage by identifying
biological pathways whose functions are required for survival
after this damage. The only other analogous genome-wide, loss-of-
function screen for MMS survival genes was performed in yeast
[14]. That study highlighted the general biological processes
required for MMS survival based on gene ontology and integrated
the identified proteins into a disorganized network [14].
Considering that pathways, whether signaling, metabolic, or
enzymatic, have long been identifiable entities, it is logical to
consider them as units within a network. Thus our experiments
focused on identifying pathways required upon exposure to
damage and validating the biological responsiveness of pathways
following this damage exposure. Our results confirmed that these
biological pathways are indeed functional in yeast, Drosophila, and
mouse cells and therefore functional contribution of these
biological pathways are pertinent to damage response in a network
representation.
In addition to the functional conservation of the survival
pathway in response to alkylation damage, these same biological
pathways appear to have roles in response to other types of
damages. It is interesting to compare our results with an elegant
study by Matsuoka et al. [4], which identified proteins that are
phosphorylated following ionizing radiation in human cells. Their
study identified proteins that are components of nine of our 13
MMS survival pathways, including four of the DNA repair
pathways, DDR, mTOR, proteasome, basal transcription, and
ribosome. These results suggest that different types of damage, not
just alkylation damage, may utilize different components of a DNA
damage survival network in a functionally conserved manner and
reemphasize the functional conservation of pathways, if not the
individual genes, between species.
Our emphasis to reorganize the MMS survival network based
on pathways is to facilitate the observation of biologically
relevant interactions. Often protein:protein interaction networks
may appear chaotic, but may be interrogated for simple sub-
networks associated with protein(s) and pathways of interest [21].
However, when working with pleiotropic responses that
encompass so many different biological processes, such as
DDR, a chaotic network representation appears non-intuitive
(Figure 6D). Thus, the integration of pathways within the
conceptual framework of systems biology networking is logical.
An additional advantage of including pathways is highlighted by
our demonstration of MMS survival protein enrichment by
detailed examination of pathways. Even with this detailed
Figure 6. Protein network of MMS survival proteins reveals an integrated, highly connected MMS survival network. (A) 150 of the
validated MMS survival proteins (red nodes) are represented in the known Drosophila interactome, with protein:protein interactions represented by
grey edges; 104 of these validated hits are ‘‘orphans,’’ not connected to other proteins. (B) Nodes and orphans from (A), including 11 proteins
essential for viability (black nodes) that are connected to two or more validated hits, improves the connectivity of the DNA damage survival network.
In this network, only 93 hits are orphans and a larger network of 36 proteins, containing 29 validated hits, is observed. (C) Nodes and orphans from
(B), including additional pathway hits not found in screen (green nodes). In this network, 86 screen hits and an additional 54 pathway hits are orphans
and a larger network of 63 proteins, containing 33 validated screen hits, 20 additional pathway hits and 10 essential proteins. (D) Nodes and orphans
from (C), including all non-hit members of the 13 MMS survival pathways (open nodes). In this network, 60 screen hits and an additional 40 pathway
hits are orphans and a larger network of 247 proteins, containing 79 validated screen hits (26 of which are within pathways), 35 additional pathway
hits, 101 non-hit pathway proteins, and 32 essential proteins. (E) Network of proteins validated to be required after MMS treatment (red nodes),
proteins essential for viability (black nodes), and 13 pathways (blue pathway nodes) validated to be involved in MMS survival. All proteins in each
pathway, regardless of being a hit, are represented in its metanode, with node size representing protein number. After all pathway components are
used to create the network, only 54 proteins are orphan, and 96 proteins are contained within the main interconnected network. Network
connectivity coefficients are given at the lower right-hand corner for (A–D).
doi:10.1371/journal.pgen.1000527.g006
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functioning as expected, we were not able to assign every protein
within each pathway as an ‘‘MMS survival protein.’’ There are
many possible explanations for this, but nonetheless, considering
the pathways as a whole provide a framework within the
network that highlights novel interactions, cross-talk, and
identified proteins not mapped to a canonical pathway, but
present within the network, would unlikely be observed in a
‘‘chaotic network view’’ and encourages their investigation. This
approach is similar to computational clustering of networks
based on signaling pathways using interactome datasets [35], but
our approach includes both identified proteins and pathway
components. Our representation is simplified, using a single
node to represent the entire pathway rather than a complex
display of interactions for every component in a pathway [36].
This simplified pathway inclusive representation reveals a highly
organized network, consistent with the requirement of each
pathway for cellular survival (Figure 6E), and provides an
effective strategy to integrate modular components into the
network [37] and thereby inferring biological properties [38].
The interconnectivity between the survival pathways
(Figure 5E) suggests potential pathway cross-talk. If such cross-
talk exists, it would be highly pertinent to cancer therapy.
Recent studies have demonstrated the utility of a global level
analysis, allowing identification of altered pathway function in
complex diseases such as the Notch pathway in pancreatic
cancer [39] and similarly the DDR pathway in breast and
colorectal cancers [40]. Considering our identification of Notch,
TOR, DDR, and the proteasome as ‘‘survival pathways,’’ all of
which are currently being explored as targets for cancer therapy
[41,42], our identified survival network would suggest the
possibility of combining pathway-specific pharmacological agents
in cancer therapy. Some of the pathway connections and
potential cross-talk represented in our survival network
(Figure 6E) have already been observed. For example, protein
phosphatase, PP2A, a downstream component of the TOR
pathway [23], interacts with the DDR component to regulate
phosphorylation of ATM and ATR [43] and vice versa [4];
DDR interacts with BER via CHK2 and XRCC1 [44]; Notch
interacts with DDR via Mastermind and p53 [45]; the
glutathione pathway interacts with the nucleotide excision repair
pathway (NER) [46]; and the proteasome interacts with various
DNA repair components [34,47]. Together, it would appear that
our model of an integrated network of conserved damage
survival pathways is both valid and biologically relevant.
In conclusion, we have identified a network of pathways that
have a functional role in damage response by affecting viability; we
also demonstrated the functional conservation between species of
the MMS survival pathways. By considering the protein
interactions between the MMS survival proteins and by incorpo-
rating the MMS survival pathways, a highly interconnected
damage survival network is observed that encompasses at least
58% of the identified MMS survival proteins directly. This
interconnectivity suggests a strong functional interrelationship
between constitutive components of the survival network and the
possibility of pathway cross-talk and coordination at a level greater
than just their instigation by the DDR pathway. Although these
MMS survival pathways have already been implicated in MMS
damage response, we have identified these seemingly disparate
pathways in a single screen, and with the network analysis, this
lends to direct connection of these pathways in response to
damage. The pleiotropic effects of alkylation damage therefore
require a wide-variety of functioning pathways in order for the cell
to survive.
Methods
Tissue culture
Kc167 cells were grown in Schneider medium (Invitrogen,
Carlsbad, CA) supplemented with 10% heat inactivated fetal
bovine serum (65uC, 10 minutes), penicillin and streptomycin at
22uC in a humidified chamber.
Primary MEFs were obtained by harvesting 14.5 day C57BL/6
embryos as previously described [48]. Briefly, fetal liver and head
were removed and the remainder of the embryo mechanically
disaggregated in plating medium. A suspension of single-cells was
plated out in Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal calf serum, 2 mM glutamine,
100 U/mL penicillin, and 100 mg/mL streptomycin. MEFs were
grown for two passages before freezing aliquots. Aliquots were
taken and expanded as needed for each experiment.
Genome-wide viability screen following MMS exposure
Methods were adapted from [49], with 1.2610
4 Kc167 cells
suspended in 10 mL of serum-free Schneider medium (Invitrogen)
added to each well of sixty-three 384-well plates. Each well
contains about 0.25 mg of a double-stranded (ds) RNA, with
22,915 individual dsRNA represented in the whole library
(Version 1 dsRNA). Cells were incubated for 1 h at 22uC, allowed
phagocytic uptake of the dsRNA, then 20 mL of serum (15% heat-
inactivated fetal bovine serum) containing medium were added
and the plates incubated for a further 72 h. Medium was
exchanged for fresh serum containing medium, with or without
0.004% (w/v) of MMS (Sigma-Aldrich, St. Louis, MO). Following
72 h additional incubation, medium was removed and the number
of viable cells assessed using pre-diluted Celltiter-Glo per
manufacturers instructions (Promega, Madison, WI). Screens were
performed in duplicate, with the replicate screen initiated on a
different day.
Production of dsRNA
dsRNA were produced similarly to previously described [8,18].
Briefly, dsRNA was synthesized using cDNA prepared by gene
specific amplification of reverse transcribed cDNA. For cDNA
preparation, RNA was harvested from adult D. melanogaster using
Trizol reagent. For gene specific amplification, primers designed
by the DRSC to target genes of interest were custom synthesized
with overhanging T7 promoter sequences (Invitrogen). DRSC
validation primer sequences were obtained from the DRSC for
targeting genes of interest, and oligonucleotides were purchased
(Invitrogen). First round PCR amplifications were performed using
gene specific primers, and the amplified products were gel
purified, using an agarose gel purification kit (Qiagen, Valencia,
CA) or a 96-well gel isolation kit (Invitrogen). The purified PCR
products were then used for second round amplification also using
the gene specific primers; these amplified products were purified
using Millipore PCR purification 96-well plate system (Millipore,
Billercia, MA). The purified products were then used for dsRNA
synthesis using T7 Ribomax express system (Promega) and
purified using the PCR purification plate system (Millipore). The
quality of purified dsRNA was verified by agarose gel electropho-
resis and, following spectrophotometric quantification, stored at
220uC.
Validation analysis
Validation of MMS survival genes was performed as previously
described [18], with the exception that DRSC ‘‘validation’’
dsRNA (targeting a gene mRNA transcript at a different location
to the library amplicon), designed by the DRSC but produced
Damage Survival Pathways
PLoS Genetics | www.plosgenetics.org 12 June 2009 | Volume 5 | Issue 6 | e1000527in-house, were preferentially used in this study. Briefly, dsRNA
were validated in quadruplicate, with one set of plates treated with
MMS and one set used as an untreated control. Plates with or
without MMS with the same dsRNA were then compared.
Genes required after MMS treatment and genes whose knock-
down conferred resistance to MMS were validated by validation
amplicons, if available. When validation amplicons were not
available, the amplicon used in the original library was used for
validation. In some instances, both validation and library
amplicons were used in validation experiments. In these cases,
the knock-down result from the validation amplicon was preferred
over that of the library amplicon, if a difference was evident. If the
gene of interest was annotated to a pathway that had already been
determined to be involved in MMS response, the gene was
considered as a hit regardless of which version amplicon validated.
Gene ontology
Gene ontology was retrieved from FlyBase (http://flybase.org/).
Enrichment analysis was conducted using FuncAssociate (http://
llama.med.harvard.edu/cgi/func/funcassociate/) for those ontol-
ogies over-represented with a p-value of less than 0.05. Those
ontology categories that overlapped were consolidated.
Westerns
Protein lysates were prepared using radioimmunoprecipitation
assay (RIPA) buffer containing 5% sodium deoxycholate, 0.1%
SDS, 0.1% Igepal in PBS with a cocktail of protease inhibitors
(1 mM PMSF, 1 mM Sodium Orthovandate and 30 uL/mL
Aprotinin (Sigma)). Protein concentration was determined using
Bradford Protein Assay Reagent (Biorad, Hercules, CA). Equal
amounts of protein were resolved using 10% SDS polyacrylamide
gel and transferred onto a nitrocellulose membrane (Hybond-
ECL, GE Healthcare Lifesciences, Piscataway, NJ). Using
appropriate dilutions of primary and secondary antibodies,
immunodetection of the protein was performed using the ECL
plus system (GE Healthcare Lifesciences). Primary antibodies
include P-Chk1 (T68) (Abcam) and total CHK1 (Abcam), P-
p70S6K (T389) (Cell Signaling Technology) and total p70S6K
(Cell Signaling Technology), and P-p53 (S15) (Cell Signaling
Technology) and total p53 (Cell Signaling Technology).
Apurinic sites measurement
Apurinic or apyrmidinic sites (AP) that were generated following
DNA damage were measured using a colorimetric assay kit for
DNA damage quantification (Oxford Biomedical Science, Oxford,
MI), following manufacturer’s protocol. Briefly, DNA was isolated
from the experimental cells using a Genomic DNA isolation kit
(Oxford Biomedical Science). Equal amounts of DNA were then
labelled using a biotinylated aldehyde reactive probe. Labelling
was followed by purification and colorimetric quantification using
streptavidin-horse radish peroxidase (HRP) conjugate and HRP-
dependent substrate supplied with the kit. The aldehyde reactive
probe labelled DNA standard, supplied by the kit, was used to
determine the number of AP sites per 100 kilobase pairs of DNA
in the experimental samples.
Glutathione measurement
Intracellular glutathione levels were measured using a colori-
metric assay kit for glutathione (Oxford Biomedical Science),
following manufacturer’s protocol. Briefly, cells from RNAi
experiments were resuspended in ice-cold PBS and homogenized
using a sonicator; the lysate was cleared by centrifugation and the
protein concentration of the supernatant was determined using
Bradford’s reagent (Biorad). For estimation of glutathione, equal
amounts of protein lysate were de-proteinized using metapho-
sphoric acid (MPA) with the final concentration of MPA adjusted
to 5%. The precipitated proteins were cleared by centrifugation at
4000 g for 10 min at 4uC, and the supernatant was used for the
assay. Reduced glutathione (Sigma) was used as a standard, and
samples were arrayed in a 96-well plate. A two-step reaction was
conducted, thioesterification of intracellular thiols using 4-choloro-
1-methyl-7-trifluoromethyl-quinolinium methylsulfate followed by
alkaline conversion of glutathione-thioester to chromophoric
thione, followed by detection of total glutathione by absorbtion
at 400 nm.
Quantitative Reverse-Transcriptase PCR
dsRNA was used to target a gene of interest; this dsRNA was
the same used to validate the genes of interest by knock-down. The
level of RNAi mediated silencing of gene expression was
monitored by quantitative real time RT–PCR using QuantiTect
SYBR Green RT-PCR kit (Qiagen GmbH) and an ABI 7500 Real
Time PCR System (Applied Biosystems, Foster City, CA). For
these experiments, 18.61610
4 Kc167 cells were dispensed into a 24-
well tissue culture plate containing 6.2 mg of dsRNA per well.
Following 1 h incubation in a serum-free condition to allow the
uptake of dsRNA, serum was replenished to a final concentration
of 10%. On Day 3, RNA was isolated using RNeasy Mini kit
(Qiagen) and quantified using an ND-1000 Spectrophotometer
(Nanodrop, Wilmington, DE). For the PCR amplifications, distinct
primers that were not encompassed within the dsRNA used to
target the gene were used. For gene expression analysis following
MMS exposure, RNA was isolated on Day 4. For experiments
with Kc167 cells, CG6905, the expression of which remained
unaltered following MMS exposure, was used as an endogenous
control. For experiments with MEFs, the isolated RNA was
reverse transcribed using an ImProm-II Reverse Transcription
System (Promega) and the cDNA was used with TaqMan Gene
Expression Assay kit for GCLc, purchased from (Applied
Biosystems, CA) and TaqMan Universal Master Mix (Applied
Biosystems). Mouse b-Actin TaqMan Gene Expression Assay kit
was used as an endogenous control. The level of gene expression
was determined using nnCt method [50].
Proteasome measurement
Experiments were performed in 384-well plates using the same
layout and timing as described for the RNAi validation
experiments, [18], except the proteasome activity was measured
on Day 4 of the experiment, 24 h after MMS exposure. For
proteasome measurement, a Proteasome-Glo assay kit was used
(Promega), as per instructions. To normalize the proteasome
activity with cell density, a parallel experiment was performed in a
separate 384-well plate, and the cell density was estimated using
CellTiter-Glo (Promega) as described above. Proteasome activity
was then normalized to the relative number of cells present.
Orthologue identification
Orthologues of Drosophila genes of interest in human, mouse,
and yeast, were obtained from Ensembl49 (http://ensembl.org/).
siRNA targeting of MEFs
SMARTPool siRNAs were purchased from Dharmacon RNA
technologies (Lafayette, CO). For siRNA transfection into MEFs,
cells were harvested by trypsinization, washed in a serum free
medium, and cell density was adjusted to 1610
6 cells in 100 mLo f
MEF-2 Nucleofector Solution (Amaxa, Gaithersburg, MD),
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electroporation using Nucleofector II Device (Amaxa). The
transfected cells were seeded in either a 96-well or a 384-well
tissue culture plate, as required by the experiment. For non-
specific control, scrambled, non-targeting siRNA was used. The
fluorescent probe siGLO red (Dharmacon) was used to monitor
the efficiency of siRNA uptake, and the efficiency of protein
knock-down was determined by western blot analysis (Figure S3B).
Additional validation for SMARTPool siRNA experiments were
performed using a minimum of four independent duplex siRNA
for each gene (Figure S10).
Pathway identification
Pathway analysis was conducted first by a priori identification of
protein/pathway relationships and KegArray, yielding from which
we included DNA damage response, glutathione metabolism, the
TOR pathway, proteasome, and DNA repair pathways. For a
systematic analysis on the MMS hits, KegArray (with default
settings) was used (http://genome.jp/download/), yielding Notch
signaling, ATPase, basal transcription, ribosome, proteasome and
glutathione metabolism. These pathways were examined for the
number of hits identified in the pathway versus the number of total
pathway components. Pathways that we included from prior
knowledge only were not top pathways retrieved by KegArray due
to their relatively small size or completeness in the KEGG
database in fly.
Interactome analysis
Protein interactome data were obtained from IntAct [27]
(http://www.ebi.ac.uk/intact/), the Database of Interacting
Proteins [28] (DIP, http://dip.doe-mbi.ucla.edu/) and the Bio-
molecular Interaction Network Database [29] (BIND, http://
bond.unleashedinformatics.com/). Data from the three databases
were combined into a single interactome, using the CG number of
each gene as the identifier of the protein. Interactomes were
visualized using Cytoscape 2.6 (http://www.cytoscape.org/).
Pathway nodes were created external to Cytoscape by renaming
all nodes representing protein in the pathways with the name of
the pathway. If a protein was found in multiple pathways, it is
represented in all relevant pathway nodes. Interactions between
pathways were trimmed if the only interaction between them also
existed within both pathways. For instance, if a protein:protein
interaction occurs between two members of the NER pathway,
and these two proteins also exist in the BER pathway, then the
interaction is more likely to be pathway specific and not cross-talk
between pathways and was therefore removed.
Connectivity analyses
Four measurements of connectivity were made: (1) Counting the
number of pairs of MMS survival proteins that directly interact in
the interaction network, (2) computing the average geodesic
distance (i.e., the number of edges in a shortest path) between each
pair of MMS survival proteins in the interaction network [51], (3)
the global efficiency of the network [51], and (4) the clustering
coefficient [51]. The number of direct interactions provides an
intuitive measure of the connectivity of a subnetwork, while the
average distance measures the global connectivity of the sub-
network. Global efficiency provides a similar measure to average
distance, but allows for disconnected components. The global
efficiency was measured by 1
NN {1 ðÞ
P
i, j~1::N, i=j
1
dij, where n is the
number of vertices in the network and dij is the geodesic distance
between vertices vi and vj. The clustering coefficient is a measure
of local connectivity of the network. For each vertex vi, let gi be the
subnetwork that consists of direct neighbours of vi (excluding vi
itself) and the edges between them. The clustering coefficient of vi
was measured by the total number of edges in gi divided by the
maximum number of edges that could possibly exist in gi. The
clustering coefficient of a network is given by the average of the
clustering coefficient of each vertex, with a high clustering
coefficient indicating a distinction between a real network from
a random one. To assess the statistical significance of each
measurement, the same number of proteins or proteins pairs, as
appropriate, were randomly sampled from the PPI or PPI
subnetwork. This sampling was repeated 1,000 times to estimate
a p-value that the difference could be expected by chance.
Statistical analyses
To determine if knock-down of genes resulted in increased
sensitivity to MMS, raw data obtained from the viability assays
was normalized and statistically analyzed as described previously
[18]. A T-test was performed between normalized quadruplicates
to determine the significant difference between treated and
untreated wells. Percent control survival with MMS treatment
was then estimated for each experimental gene knock-down as
described previously [18], and a second T-test was performed on
the percent of viability as compared with luciferase control within
each plate as described before [18]. From these analyses,
significant hits were selected as death hits if there was no greater
than 55% viability in treated wells as compared to untreated if a p-
value of less than 0.05 resulted from at least one of the T-tests. For
those genes with an essential phenotype of less than 40% viability
of non-targeting dsRNA, more stringent requirements were made
on the viability effect after MMS treatment, such that 30–40%
viability when untreated needed 15% viability after MMS
treatment, 20–30% needed 10% after treatment, 10–20% needed
5% after treatment, and 0–10% was too dead to determine if
MMS had an effect. Genes were considered ‘‘trend death hits’’ if
they exhibited less than 55% viability after treatment but did not
have a p-value with significance or if they exhibited 55–65%
viability after MMS treatment with a significant p-value. Knock-
down of genes resulting in resistance to MMS were confirmed as
those with greater than 85% viability after treatment as compared
to untreated wells, with one of the two p-values of less than 0. 0001
and viability after no treatment to be at least 60% that of non-
targeting knock-down.
To determine if a gene was essential for viability, a T-test was
performed on untreated wells comparing values for non-targeting
dsRNA against luciferase and dsRNA targeting the gene. If the
targeting dsRNA resulted in less than 70% viability of luciferase
with a p-value of less than 0.00001, the gene was deemed essential.
Comparisons between predicted and observed numbers of
MMS survival genes between yeast and Drosophila studies were
done by a standard G-test [52]. The G-test is equivalent to a
contingency Chi-square test but allows for classes with zero
events.
To determine protein enrichment within a pathway where there
is an unbalanced distribution of data between the numbers of
proteins within a pathway compared to the total number of genes
within a genome, a Fisher’s Exact test was employed [53].
For connectivity measurements, except in the case of clustering
coefficient, p-values were estimated using a Z-test, given that the
connectivity measurement for the random subnetworks approxi-
mately follows a normal distribution (Table S6). The p-value for
the clustering coefficient measurement was estimated by simply
counting the frequency that the clustering coefficient of a
randomly sampled sub-network was at least as high as that of
the real sub-network.
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Figure S1 The MMS dose response as measured by cell survival.
Viability of Drosophila Kc167 cells following exposure to increasing
dose of MMS determined using CellTiter-Glo (relative light units
(ordinate) for increasing dose of MMS (abscissa)).
Found at: doi:10.1371/journal.pgen.1000527.s001 (0.54 MB EPS)
Figure S2 Four of the eight additional pathways utilized for
MMS survival. CG numbers are given for each Drosophila pathway
component, as well as the protein names or complex names for
their human orthologues. Pathway entry points are noted with
Roman numerals at the top, and end points are at the bottom. A
key for the following symbols is provided. Symbols encircled with
thick lines represent proteins that act together or in a complex,
while symbols encircled with thin lines represent paralogues or
proteins that may substitute for one another. Proteins found to
affect MMS survival are noted as down (death) or up triangles
(resistance). Statistically significant proteins are indicated with
black triangles, while trend hits are indicated with grey triangles.
Essential genes are noted with a thick bar and any with
downwards or upwards pointing boxes were also validated as
conferring death or resistance, respectively, to MMS upon knock-
down. Shaded squares are proteins not found to be hits after
validation, and open squares were not tested in our validation.
Yeast orthologues previously found to be required for MMS
survival [3] are noted with a dot under the symbol. An example of
average percent of untreated control survival of validated hits is
shown next to each pathway, though this may not represent the
actual control for each data point within the graph. Error bars are
the standard deviation of quadruplicates. Survival of control cells
with dsRNA targeting luciferase is shown in an open bar, protein
knock-down that resulted in a significant difference in MMS
survival from this control are shown in black (death) or stripped
(resistance), and those with a trend effect are shown in grey. A
complete list of these proteins and their human and yeast
orthologues is given in Table S6. (A) Nucleotide Excision Repair.
(B) Mismatch Repair. (C) Homologous Recombination Repair. (D)
RecQ Helicases.
Found at: doi:10.1371/journal.pgen.1000527.s002 (1.40 MB EPS)
Figure S3 Two of the eight additional pathways utilized for
MMS survival. CG numbers are given for each Drosophila pathway
component, as well as the protein names or complex names for
their human orthologues. Pathway entry points are noted with
Roman numerals at the top, and end points are at the bottom. A
key for the following symbols is provided. Symbols encircled with
thick lines represent proteins that act together or in a complex,
while symbols encircled with thin lines represent paralogues or
proteins that may substitute for one another. Proteins found to
affect MMS survival are noted as down (death) or up triangles
(resistance). Statistically significant proteins are indicated with
black triangles, while trend hits are indicated with grey triangles.
Essential genes are noted with a thick bar and any with
downwards or upwards pointing boxes were also validated as
conferring death or resistance, respectively, to MMS upon knock-
down. Shaded squares are proteins not found to be hits after
validation, and open squares were not tested in our validation.
Yeast orthologues previously found to be required for MMS
survival [3] are noted with a dot under the symbol. An example of
average percent of untreated control survival of validated hits is
shown next to each pathway, though this may not represent the
actual control for each data point within the graph. Error bars are
the standard deviation of quadruplicates. Survival of control cells
with dsRNA targeting luciferase is shown in an open bar, protein
knock-down that resulted in a significant difference in MMS
survival from this control are shown in black (death) or stripped
(resistance), and those with a trend effect are shown in grey. A
complete list of these proteins and their human and yeast
orthologues is given in Table S6. (A) Basal Transcription. (B)
Ribosome.
Found at: doi:10.1371/journal.pgen.1000527.s003 (3.26 MB EPS)
Figure S4 Two of the eight additional pathways utilized for
MMS survival. CG numbers are given for each Drosophila pathway
component, as well as the protein names or complex names for
their human orthologues. Pathway entry points are noted with
Roman numerals at the top, and end points are at the bottom. A
key for the following symbols is provided. Symbols encircled with
thick lines represent proteins that act together or in a complex,
while symbols encircled with thin lines represent paralogues or
proteins that may substitute for one another. Proteins found to
affect MMS survival are noted as down (death) or up triangles
(resistance). Statistically significant proteins are indicated with
black triangles, while trend hits are indicated with grey triangles.
Essential genes are noted with a thick bar and any with
downwards or upwards pointing boxes were also validated as
conferring death or resistance, respectively, to MMS upon knock-
down. Shaded squares are proteins not found to be hits after
validation, and open squares were not tested in our validation.
Yeast orthologues previously found to be required for MMS
survival [3] are noted with a dot under the symbol. An example of
average percent of untreated control survival of validated hits is
shown next to each pathway, though this may not represent the
actual control for each data point within the graph. Error bars are
the standard deviation of quadruplicates. Survival of control cells
with dsRNA targeting luciferase is shown in an open bar, protein
knock-down that resulted in a significant difference in MMS
survival from this control are shown in black (death) or stripped
(resistance), and those with a trend effect are shown in grey. A
complete list of these proteins and their human and yeast
orthologues is given in Table S6. (A) ATPases. (B) Notch.
Found at: doi:10.1371/journal.pgen.1000527.s004 (2.47 MB EPS)
Figure S5 Average percent of untreated control survival of
validated hits in each pathway represented in Figures 2 and 3.
Error bars are the standard deviation of quadruplicates. Survival
of control cells with dsRNA targeting luciferase is shown in an
open bar as an average across all plates as a general reference. It
should be noted that each plate had its own luciferase controls
against which all plate values were compared. Protein knock-down
that resulted in a significant difference in MMS survival from their
internal plate control are shown in black (death) or dashed
(resistance), and those with a trend effect are shown in grey. A
complete list of these proteins and their human and yeast
orthologues is given in Table S6.
Found at: doi:10.1371/journal.pgen.1000527.s005 (4.48 MB EPS)
Figure S6 Efficiency of RNAi mediated silencing of gene
expression. (A) RNAi transfection resulted in decreased expression
of target mRNA in Drosophila Kc167 cells, measured by quantitative
real time PCR as indicated percent control gene expression
(ordinate) for the genes (abscissa) tested, with expression
normalized to endogenous control (CG6905). (B) Western blot
analysis for efficiency of RNAi in siRNA transfected primary
mouse embryonic fibroblast cells.
Found at: doi:10.1371/journal.pgen.1000527.s006 (0.74 MB EPS)
Figure S7 MMS exposure results in a dose-dependent increase
in 8-oxoguanine DNA modifications. The MMS-dependent
increase in 8-oxoguanine is (A) observed qualitatively by
Damage Survival Pathways
PLoS Genetics | www.plosgenetics.org 15 June 2009 | Volume 5 | Issue 6 | e1000527microscopic examination with 8-oxoguanine containing cells
observed by fluorescence in the FITC channel and this (B) can
be quantified as a percentage of fluorescent within a field
(ordinate) for increasing dose of MMS (abscissa).
Found at: doi:10.1371/journal.pgen.1000527.s007 (7.71 MB EPS)
Figure S8 Temozolomide exposure results in functional re-
sponse by MMS survival pathways in mouse embryonic
fibroblasts. (A) Temozolomide exposure results in phosphorylation
of p53 and in an accumulation of total p53 levels. (B)
Temozolomide exposure results in an increased amount of total
glutathione. The intracellular glutathione concentration is ex-
pressed as units of activity/cell. (C) Proteasome activity is
increased following temozolomide exposure, normalizing the
activity to the number of cells using a parallel viability assessment.
Proteasome activity is expressed as units of activity/cell,
normalizing the activity to the number of cells using a parallel
viability assessment.
Found at: doi:10.1371/journal.pgen.1000527.s008 (0.71 MB EPS)
Figure S9 MMS and Temozolomide exposure results in
functional response by notch signalling pathway in HEK 293
cells. MMS and temozolomide exposure results in decreased
luciferase activity of the notch reporter RBP-Jk, normalized for
transfection efficiency in HEK 293 cells using renilla luciferase.
Found at: doi:10.1371/journal.pgen.1000527.s009 (0.41 MB EPS)
Figure S10 Validation of pathway functions with additional
siRNA knock down in mouse embryonic fibroblasts. (A) Knock-
down of GCLc with four different siRNA results in decreased
GCLc expression in mouse cells, by quantitative real-time PCR
analysis; expression level is provided as fold-change compared to
an endogenous control (mouse b-actin). (B) MMS results in an
increased amount of total glutathione, and this increase is
dependent upon the rate limiting glutathione metabolizing enzyme
glutamate-cysteine ligase (GCLc). (C) Knock-down of proteasome
components Psmc1 or Psmd1 with four different siRNA results in
decreased gene expression in mouse cells, by quantitative real-time
PCR analysis; expression level is provided as fold-change
compared to an endogenous control (mouse b-actin). (D)
Proteasome activity is increased following MMS exposure in a
manner that is dependent upon proteasome components Pmsc1
and Psmd1.
Found at: doi:10.1371/journal.pgen.1000527.s010 (0.81 MB EPS)
Table S1 Summary of MMS screen hits and pathway genes
selected for validation. The 534 Drosophila MMS screen hits
selected for validation analysis and 298 pathway genes tested for
pathway analysis, provided with FlyBase gene number, corre-
sponding CG number, and the dsRNA used for validation, noted
by DRSC identification number, either library dsRNA or
validation dsRNA. For those genes that had no validation
amplicon designed or those whose library amplicon had no
potential off-target effects at 19 nt, data from [18] was used
(asterisks). For each dsRNA, significant death, trend death or
significant resistance to MMS treatment is noted (MMS survival).
Found at: doi:10.1371/journal.pgen.1000527.s011 (0.94 MB
XLS)
Table S2 Raw, normalized, and survival data for validation
experiment. For data normalization, raw data of untreated control
and MMS experiments were normalized using luciferase (Luc) and
high MMS controls and statistical significance was determined as
described [18].
Found at: doi:10.1371/journal.pgen.1000527.s012 (0.23 MB
XLS)
Table S3 List of yeast MMS hits and their fly orthologues. Yeast
MMS hits as determined by Begley et al. [3], and their fly
orthologues that were neither a hit in our MMS screen nor in a
pathway identified from the screen. Also given is whether each fly
gene was essential, a resistance hit, a death hit, or a death tread
after validation with an independent dsRNA.
Found at: doi:10.1371/journal.pgen.1000527.s013 (0.04 MB
XLS)
Table S4 Drosophila GST family members and their involvement
in MMS survival. The five GST families and their component
members. Provided is the gene name, corresponding CG number,
whether they validated as a significant MMS survival gene (death),
a trend (death trend) or not involved in MMS survival (no). For
each validation observed to have an effect, the type of amplicon,
library or validation is given. It is also noted for any validated
MMS survival gene whether the effect was also observed in the
screen. If validation was not performed this is also noted (not
tested).
Found at: doi:10.1371/journal.pgen.1000527.s014 (0.02 MB
XLS)
Table S5 Summary of the number of MMS survival genes
identified per MMS survival pathway (BER: base excision repair;
DDR: DNA damage response; Proteasome; GSH: glutathione
synthesis; TOR: TOR pathway; NER: nucleotide excision repair;
MMR: mismatch repair; HRR: homologous recombination
repair; RECQ: RecQ helicases; Transcription: basal transcription;
Ribosome; ATPase; Notch: Notch signaling pathway), and the
percentage non-essential genes of each pathway that this
represents. Protein enrichment within each pathway compared
to the number of genes that validated (202 of 13826 prior to
pathway analysis and 307 of 13826 including pathway analysis) is
determined using a Fisher’s Exact Test (NS: Not Significant; NA:
Not Applicable).
Found at: doi:10.1371/journal.pgen.1000527.s015 (0.51 MB PDF)
Table S6 The orthologous relationship between the MMS
survival genes identified in the Drosophila and yeast MMS survival
screens. Provided are the 13 MMS survival pathway, the gene
names of each Drosophila component and their corresponding CG
number. For each of these Drosophila genes, the yeast ORF is
provided for any identifiable yeast orthologue and whether it was
observed as being involved in MMS survival (hit) in S. cerevisiae by
Begley et al. [3], if it was not identified (not hit) or if it is essential
(essential). Where orthologues between the species are known and
taking into account the yeast essential genes that could not be
assayed for their effect on MMS survival, there is a clear
enrichment in MMS survival genes within the majority of
pathways examined between the two species. A complete list of
these proteins and their human orthologues are also given.
Found at: doi:10.1371/journal.pgen.1000527.s016 (0.11 MB
XLS)
Table S7 Connectivity analysis of MMS survival genes identified
by the RNAi genomic screen and following validation analyses.
Provided are the number of proteins identified, the number of
those proteins that are within the protein:protein interactome
(PPI), the number of direct connections between these proteins,
the average distance between every possible pair of proteins within
the network compared to the expected values, the global efficiency
and the clustering coefficient. For each measurement the expected
number of direct interactions is derived from the same number of
proteins randomly selected 1000 times from the PPI. Analyses are
provided for the proteins identified by the MMS screen prior to
validation (Screen hits), those screen hits that actually validated
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are connected to two or more hits (Validated+essential connec-
tors), the total number of validated MMS survival proteins
identified by both screen and pathway validation (Validated+path-
way hits), the Validated and pathway hits and the essential
proteins that are connected to two or more hits (Validated+path-
way hits+essential connectors), the total number of validated MMS
survival proteins and all other components of the 13 MMS survival
pathways (Validated+all in pathways), and finally the total number
of validated MMS survival proteins, all other components of the
13 MMS survival pathways and the essential proteins that are
connected to two or more hits or pathway proteins (Validated+all
in pathways+essential connectors). Analyses were also provided to
compare connectivity of real and randomly rewired PPI.
Found at: doi:10.1371/journal.pgen.1000527.s017 (0.19 MB
DOC)
Text S1 Methods for 8-oxo-guanine assay and notch reporter
analysis.
Found at: doi:10.1371/journal.pgen.1000527.s018 (0.03 MB
DOC)
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